These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 20136960

  • 1. Fecal lactoferrin, myeloperoxidase and serum C-reactive are effective biomarkers in the assessment of disease activity and severity in patients with idiopathic ulcerative colitis.
    Masoodi I, Kochhar R, Dutta U, Vaishnavi C, Prasad KK, Vaiphei K, Kaur S, Singh K.
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1768-74. PubMed ID: 20136960
    [Abstract] [Full Text] [Related]

  • 2. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Dobos GJ.
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [Abstract] [Full Text] [Related]

  • 3. [Significance of fecal lactoferrin in evaluation of disease activity in ulcerative colitis].
    Xiang JY, Ouyang Q, Li GD.
    Zhonghua Yi Xue Za Zhi; 2007 Aug 28; 87(32):2262-4. PubMed ID: 18001547
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Correlation of serum biomarkers with clinical severity and mucosal inflammation in Chinese ulcerative colitis patients.
    Lok KH, Ng CH, Hung HG, Li KF, Li KK, Szeto ML.
    J Dig Dis; 2008 Nov 28; 9(4):219-24. PubMed ID: 18959594
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lactoferrin in whole gut lavage fluid as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins.
    Kayazawa M, Saitoh O, Kojima K, Nakagawa K, Tanaka S, Tabata K, Matsuse R, Uchida K, Hoshimoto M, Hirata I, Katsu K.
    Am J Gastroenterol; 2002 Feb 28; 97(2):360-9. PubMed ID: 11866274
    [Abstract] [Full Text] [Related]

  • 11. Neutrophil and Eosinophil Granule Proteins as Potential Biomarkers of Assessing Disease Activity and Severity in Patients With Ulcerative Colitis.
    Li Z, Long Y, Bai M, Li J, Feng Z.
    J Clin Lab Anal; 2016 Sep 28; 30(5):776-8. PubMed ID: 27076259
    [Abstract] [Full Text] [Related]

  • 12. Role of fecal calprotectin in the diagnosis and treatment of segmental colitis associated with diverticulosis.
    Tursi A, Elisei W, Giorgetti G, Aiello F, Brandimarte G.
    Minerva Gastroenterol Dietol; 2011 Sep 28; 57(3):247-55. PubMed ID: 21769075
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.
    Langhorst J, Junge A, Rueffer A, Wehkamp J, Foell D, Michalsen A, Musial F, Dobos GJ.
    Am J Gastroenterol; 2009 Feb 28; 104(2):404-10. PubMed ID: 19174795
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB, Terrin G, Rapacciuolo L, Miele E, Siani MC, Puzone C, Cosenza L, Staiano A, Troncone R.
    Dig Liver Dis; 2008 Jul 28; 40(7):547-53. PubMed ID: 18358796
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.